VCP/p97 as a therapeutic target in KRAS-mutant pancreatic cancer

A new research paper, titled “VCP/p97, a pleiotropic protein regulator of the DNA damage response and proteostasis, is a potential therapeutic target in KRAS-mutant pancreatic cancer,” was published in Genes & Cancer on March 10, 2023.

Leave A Comment

Your email address will not be published. Required fields are marked *